Danyel Kay Wilson, MA, CCC-SLP - Medicare Speech-Language Pathologist in Muncie, IN

Danyel Kay Wilson, MA, CCC-SLP is a medicare enrolled "Speech-language Pathologist" physician in Muncie, Indiana. Her current practice location is 4870 E Jackson St, Muncie, Indiana. You can reach out to her office (for appointments etc.) via phone at (765) 254-9717.

Danyel Kay Wilson is licensed to practice in Indiana (license number 22007439A) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1205300126.

Contact Information

Danyel Kay Wilson, MA, CCC-SLP
4870 E Jackson St,
Muncie, IN 47303-4432
(765) 254-9717
Not Available



Physician's Profile

Full NameDanyel Kay Wilson
GenderFemale
SpecialitySpeech-language Pathologist
Location4870 E Jackson St, Muncie, Indiana
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1205300126
  • Provider Enumeration Date: 01/14/2019
  • Last Update Date: 02/21/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 1850729518
  • Enrollment ID: I20200312001194

Medical Identifiers

Medical identifiers for Danyel Kay Wilson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1205300126NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0213XPathology - Pediatric Pathology 46003497A (Indiana)Secondary
235Z00000XSpeech-language Pathologist 22007439A (Indiana)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Danyel Kay Wilson allows following entities to bill medicare on her behalf.
Entity NameIndiana University Health Ball Memorial Hospital, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073164646
PECOS PAC ID: 5698688273
Enrollment ID: O20191121003172

News Archive

3D MRI enhances visualization, displays fetal anatomy and diagnosing problems

Three-dimensional MRI is an emerging and useful technique for displaying fetal anatomy and diagnosing problems in the womb in a wide spectrum of clinical applications, according to Jeffrey C. Hellinger, M.D., a pediatric imaging specialist at Stony Brook University Medical Center.

CPSC, USFA offer safety tips after Hurricane Irene strikes

The U.S. Consumer Product Safety Commission (CPSC) and U.S. Fire Administration (USFA) are warning residents in hurricane-impacted areas about the deadly dangers that can remain even after Hurricane Irene strikes.

Opinion pieces address Global Fund's future after cancellation of Round 11 grants

The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to cancel Round 11 grant approval during a two-day meeting in Accra, Ghana, that concluded on November 22, according to a Global Fund press release (11/23).

Thiol-based mucolytics show potent allosteric inhibition of SARS-CoV-2-ACE2 binding via disulfide reduction

A compelling report, recently released on the bioRxiv* preprint server, describes unexpectedly powerful inhibition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by thiol-based mucolytic compounds P2119 and P2165, by preventing the virus spike from binding to its host cell receptor, the angiotensin-converting enzyme 2 (ACE2).

VentiRx announces VTX-1463 trial results for allergic rhinitis treatment

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Danyel Kay Wilson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Danyel Kay Wilson, MA, CCC-SLP
4870 E Jackson St,
Muncie, IN 47303-4432

Ph: (765) 254-9717
Danyel Kay Wilson, MA, CCC-SLP
4870 E Jackson St,
Muncie, IN 47303-4432

Ph: (765) 254-9717

News Archive

3D MRI enhances visualization, displays fetal anatomy and diagnosing problems

Three-dimensional MRI is an emerging and useful technique for displaying fetal anatomy and diagnosing problems in the womb in a wide spectrum of clinical applications, according to Jeffrey C. Hellinger, M.D., a pediatric imaging specialist at Stony Brook University Medical Center.

CPSC, USFA offer safety tips after Hurricane Irene strikes

The U.S. Consumer Product Safety Commission (CPSC) and U.S. Fire Administration (USFA) are warning residents in hurricane-impacted areas about the deadly dangers that can remain even after Hurricane Irene strikes.

Opinion pieces address Global Fund's future after cancellation of Round 11 grants

The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria decided to cancel Round 11 grant approval during a two-day meeting in Accra, Ghana, that concluded on November 22, according to a Global Fund press release (11/23).

Thiol-based mucolytics show potent allosteric inhibition of SARS-CoV-2-ACE2 binding via disulfide reduction

A compelling report, recently released on the bioRxiv* preprint server, describes unexpectedly powerful inhibition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by thiol-based mucolytic compounds P2119 and P2165, by preventing the virus spike from binding to its host cell receptor, the angiotensin-converting enzyme 2 (ACE2).

VentiRx announces VTX-1463 trial results for allergic rhinitis treatment

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.

Read more News

› Verified 4 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.